Loading…
New Product Planning Summit has ended

Sign up or log in to bookmark your favorites and sync them to your phone or calendar.

Tuesday, February 2
 

11:00am EST

Opening Remarks
Speakers
avatar for Tony Russell, Ph.D., M.B.A.

Tony Russell, Ph.D., M.B.A.

Executive Director, New Product Planning, Chinook Therapeutics, Inc.
Tony Russell is currently the Head and Executive Director of New Product Planning at Chinook Therapeutics with a focus on developing precision medicines for kidney diseases. With over 20 years of industry experience, Tony has worked across multiple facets in the biopharmaceutical... Read More →


Tuesday February 2, 2021 11:00am - 11:05am EST

11:05am EST

Keynote: Portfolio Management: Prioritizing Your Pipeline
  • Demonstrate how the role of portfolio management is evolving due to factors like shrinking pipelines, rising costs, reimbursement issues, and regulatory pressures 
  • Consider the right variables to make decisions that will meet corporate goals and consumer demands 
  • Determine where to prioritize budget and resources based on your scientific and commercial opportunity 

Speakers
avatar for Janet Dorling, MBA

Janet Dorling, MBA

Senior Vice President, Global Commercial Product Strategy, Gilead Sciences
Janet Dorling is a dynamic leader with more than 20 years of experience in science and business. She leads Global Commercial Product Strategy at Gilead, the team that provides the Commercial voice into the R&D process as well as global positioning, branding and access strategies for... Read More →


Tuesday February 2, 2021 11:05am - 11:30am EST

11:35am EST

Panel: Optimize Your Company’s NPP Organizational Structure and Process
  • Deliberate over the stage at which different resources, including market research, competitive intelligence, market access, pricing risk mitigation, etc., should get involved in NPP 
  • Assess what techniques or methodologies people are using to tackle their day to day  
  • Drive innovation early on when faced with limited resources 

Moderators
avatar for Anne Ollivier

Anne Ollivier

Director, New Product Planning, Global Strategic Marketing, Lundbeck
Accomplished value “hunter” across the value pharma chain with 15 years’ experience of finding growth opportunities, from early clinical phases, all the way through launching brands, LCM and LoE strategies. My hunting tools: a broad marketing experience to master prescribers... Read More →

Speakers
avatar for Chris Benecchi

Chris Benecchi

Vice President, Global Head of Commercial Excellence, Alexion Pharmaceuticals
Chris has consistently delivered novel therapies to those suffering from serious conditions in both specialty care and rare disease. Through experience in US and Global commercial leadership roles at J&J, Takeda, Acorda, UCB, and now Alexion, Chris has a distinct perspective on critical... Read More →
avatar for Buket Grau

Buket Grau

Vice President, Head of Early and External Product Commercialization, Biogen
Buket Grau brings more than 20 years of commercial, strategic, and operations experience in the healthcare industry. She is currently Head of the Early and External Product Commercialization group at Biogen. Previously at Biogen, Ms. Grau served as Asset Executive for the Acute Neurology... Read More →
avatar for Avi Kogan, Ph.D.

Avi Kogan, Ph.D.

Senior Director, Head of New Product Commercialization, Alnylam Pharmaceuticals
Avi Kogan is the Head of New Product Commercialization at Alnylam, where he leads commercial strategy and market opportunity assessments for research, candidate, and early stage clinical programs.  Avi was previously a New Products Leader at Takeda; led Multiple Sclerosis franchise... Read More →


Tuesday February 2, 2021 11:35am - 12:20pm EST

12:20pm EST

“Meet the Speakers” Zoom Party
Missing out on the networking aspect of live events? Your question didn’t get answered during the Q&A portion of a session? Grab a snack and mingle with today’s speakers and attendees in this zoom breakout room.

Tuesday February 2, 2021 12:20pm - 12:50pm EST

12:50pm EST

Delineate the Challenges of Innovation: Technology Overdrive, Pricing, and Forecasting
  • Innovating yourself out of existence – When smart science goes into overdrive? 
  • The price of cure – Has innovation exceeded drug pricing? 
  • Drug combination development – What do we need to see and what does it take? 

Speakers
avatar for Alexander Brown

Alexander Brown

Vice President, Global Head, New Product Planning Oncology, Sanofi Genzyme
Alex Brown has 25 years of experience developing and commercializing innovative medicines in oncology, rare and infectious diseases. In his current role Alex leads the New Products Oncology team at Sanofi-Genzyme and is responsible for the commercial readiness of the Sanofi oncology... Read More →


Tuesday February 2, 2021 12:50pm - 1:20pm EST

1:25pm EST

Panel: Connect Supply Strategies to New Product Plans Early
  • Evaluate how and when to include supply chain in the decision-making process to drive global expansion 
  • Explore how you can speed to market with increasingly underdeveloped products 
  • Consider the effect cost of good could have on pricing implications 
  • Planning localization efforts early 

Moderators
avatar for Michael Boyson

Michael Boyson

Vice President, Product Operations for Oncology and Small Molecules, Takeda Pharmaceuticals
Mike is responsible for global operations strategy, including life-cycle planning and overall operations value management for Takeda’s oncology portfolio and select small molecule therapies.  Mike joined Takeda Oncology in 2002.  Since that time, he has held various positions... Read More →

Speakers
avatar for Ram Palanki, PharmD

Ram Palanki, PharmD

Senior Vice President, Commercial Strategy & Operations, REGENXBIO Inc.
Ram has nearly 20 years of drug development and commercialization experience in biopharmaceutical industry.  He built and operationalized commercial infrastructures and launched landmark drug therapies and devices in ophthalmology.Currently, he serves as the Senior Vice President... Read More →
avatar for Csanad Varga, Ph.D.

Csanad Varga, Ph.D.

Vice President, Pharmaceutical Sciences & Manufacturing, Blueprint Medicines
Csanad “Csani” Varga, Ph.D. is the Vice President of Pharmaceutical Sciences & Manufacturing at Blueprint Medicines, responsible for the pharmaceutical development and manufacturing oversight, including drug substance, drug product, and analytical development, for Blueprint’s... Read More →


Tuesday February 2, 2021 1:25pm - 2:10pm EST

2:10pm EST

"Meet the Speakers" Zoom Party
Missing out on the networking aspect of live events? Your question didn’t get answered during the Q&A portion of a session? Grab a snack and mingle with today’s speakers and attendees in this zoom breakout room.

Tuesday February 2, 2021 2:10pm - 2:40pm EST
 
Wednesday, February 3
 

11:00am EST

Opening Remarks
Speakers
avatar for Tony Russell, Ph.D., M.B.A.

Tony Russell, Ph.D., M.B.A.

Executive Director, New Product Planning, Chinook Therapeutics, Inc.
Tony Russell is currently the Head and Executive Director of New Product Planning at Chinook Therapeutics with a focus on developing precision medicines for kidney diseases. With over 20 years of industry experience, Tony has worked across multiple facets in the biopharmaceutical... Read More →


Wednesday February 3, 2021 11:00am - 11:05am EST

11:05am EST

Keynote: Incorporate External Insights into Pipeline Decisions
  • How can we think about incorporating external insights from various stakeholder groups into key decision points along product development? 
  • Can we weave this into our decision-making process?
  • Who are these stakeholder groups and how do their insights help make stronger decisions? 



Speakers
avatar for Aakanksha Khandelwal, Ph.D., MBA

Aakanksha Khandelwal, Ph.D., MBA

Global Head of Portfolio Strategy & Innovation, EMD Serono
Aakanksha is the Head of Global Portfolio Strategy & Innovation at EMD Serono/Merck KGaA, Darmstadt, Germany. She is a cross-functional leader with grounding in both the R&D and commercial sides of the business.​Prior, Aakanksha led the commercial launch of BAVENCIO while building... Read More →


Wednesday February 3, 2021 11:05am - 11:30am EST

11:35am EST

Panel: Navigating the Early Commercial Strategy Waters: Cell Therapy vs. Non-Cell Therapy
  • Assess key stakeholders in a medication’s lifecycle and how they should impact NPP
  • Discuss critical elements to NPP within the context of cell therapy and non-cell therapy
  • Determine key challenges for various product categories and how to mitigate them

Moderators
avatar for Tony Russell, Ph.D., M.B.A.

Tony Russell, Ph.D., M.B.A.

Executive Director, New Product Planning, Chinook Therapeutics, Inc.
Tony Russell is currently the Head and Executive Director of New Product Planning at Chinook Therapeutics with a focus on developing precision medicines for kidney diseases. With over 20 years of industry experience, Tony has worked across multiple facets in the biopharmaceutical... Read More →

Speakers
avatar for Lung-I Cheng, Ph.D.

Lung-I Cheng, Ph.D.

Global Value & Access Lead, Cell Therapies, Takeda
Lung-I Cheng, PhD, is Global Value & Access Lead, Cell Therapies at Takeda Pharmaceuticals. In this role, he leads the access strategy for Takeda's portfolio of cell therapy assets in oncology. Prior to this, he oversaw the market access efforts for the company's lymphoma franchise... Read More →
avatar for Kelly Page

Kelly Page

Head of Global Cell Therapy Commercialization, Takeda
Kelly Page is Head of Global Cell Therapy Commercialization, Global Oncology Business Unit at Takeda Pharmaceuticals. Previous roles within Takeda’s Oncology Business Unit have included Country Head for Germany and Global Development Lead for ADCETRIS, where she oversaw the first... Read More →
avatar for Jennifer Sherak

Jennifer Sherak

Global Head, Oncology New Products, Takeda
Jennifer is currently the Global Head of Oncology New Product Planning Business Development at Takeda Pharmaceuticals. In her current role, she is responsible for ensuring that the value of the oncology pipeline is maximized globally by integrating commercial insights early in development... Read More →


Wednesday February 3, 2021 11:35am - 12:20pm EST

12:20pm EST

"Meet the Speakers" Zoom Party
Missing out on the networking aspect of live events? Your question didn’t get answered during the Q&A portion of a session? Grab a snack and mingle with today’s speakers and attendees in this zoom breakout room.

Wednesday February 3, 2021 12:20pm - 12:50pm EST

12:50pm EST

Making Key Decisions in New Product Planning When “Perfect” Information is Not Available
  • Review the types of decisions typically made in New Product Planning 
  • Discuss the nature of information available to support decision-making in New Product Planning 
  • Review the impact and context of decision-making in New Product Planning 
  • Review potential approaches to assist in New Product Planning decision-making 

Speakers
avatar for Tony Russell, Ph.D., M.B.A.

Tony Russell, Ph.D., M.B.A.

Executive Director, New Product Planning, Chinook Therapeutics, Inc.
Tony Russell is currently the Head and Executive Director of New Product Planning at Chinook Therapeutics with a focus on developing precision medicines for kidney diseases. With over 20 years of industry experience, Tony has worked across multiple facets in the biopharmaceutical... Read More →


Wednesday February 3, 2021 12:50pm - 1:20pm EST

1:25pm EST

Panel: How Does Working in the Covid-19 Era Affect Forecasting and New Product Planning
  • Discuss when in the product pipeline to begin forecasting, and how covid-19 has affected that timeline  
  • Determine the best resources to use for forecasting  
  • Consider which functional areas forecasting has an influence on and how   
  • What has worked for different companies? What has been challenging?   

Moderators
avatar for Alex Drigan, MBA

Alex Drigan, MBA

Senior Director, Commercial Operations, Amneal Pharmaceuticals
Alex Drigan is a senior leader with extensive experience in sales, marketing and operations in both Canada and the U.S.  His roles span numerous industries including Pharmaceutical, Healthcare, Consumer Packaged Goods, Plastics and B2B.  Companies worked for include Amneal Pharmaceuticals... Read More →

Speakers
avatar for Charlie Pak, Ph.D., MBA

Charlie Pak, Ph.D., MBA

Executive Director, New Product Planning, Alkermes
Charlie Pak is currently the Executive Director of New Product Planning at Alkermes with responsibility across oncology and neuroscience.  He has extensive new product planning experience at various companies, including Syros Pharmaceuticals, ImmunoGen, Eisai, and Vertex Pharmaceuticals... Read More →
avatar for Roman Rudinskiy, MBA

Roman Rudinskiy, MBA

Director of Forecasting, Helsinn Group
Roman Rudinskiy is the Director of Forecasting at Helsinn Therapeutics specializing in the areas of rare diseases, oncology, and oncology support products.He earned his Bachelor of Science in Pharmacy from the Long Island University and MBA in Marketing and Finance at NYU Stern School... Read More →
avatar for Cyril Thomson

Cyril Thomson

Director, Global Commercial Forecasting and Decision Analytics, CSL Behring
Cyril Thomson is currently the Global lead for forecasting and decision analytics across all of the CSLB portfolio. Prior to his role at CSLB, Cyril was a Principal at IQVIA leading the COS forecasting and analytics practice supporting multiple pharma/biopharma clients. He experience... Read More →


Wednesday February 3, 2021 1:25pm - 2:10pm EST

2:10pm EST

"Meet the Speakers" Zoom Party
Missing out on the networking aspect of live events? Your question didn’t get answered during the Q&A portion of a session? Grab a snack and mingle with today’s speakers and attendees in this zoom breakout room.

Wednesday February 3, 2021 2:10pm - 2:40pm EST

2:40pm EST

Patient Journey in Pharma - Why, how and when
•    Demonstrate the value of deep insights from the patient journey for new product valuation and commercial strategy 
•    Review a step-by-step approach to develop a patient journey in both small and large organizations 
•    Discuss when and how often the patient journey should be updated and refined  

Speakers
avatar for Katja Wachtendonk, PharmD

Katja Wachtendonk, PharmD

Executive Director, Global Marketing (New Products), Novartis
Katja Wachtendonk is a pharmaceutical industry leader experienced across multiple geographies  (Global, US, Germany & Japan), therapeutic areas (primary care, specialty, rare and genetic diseases) from early drug development to launch and commercialization.  In her current role... Read More →


Wednesday February 3, 2021 2:40pm - 3:10pm EST

3:15pm EST

Panel: Assess how a Target Product Profile Can Help Guide R&D, Regulatory, and Other Stakeholders
  • Outline how a TPP can set up your clinical program and commercial model for success 
  • Determine how to develop an insights program that allows you to get the information and apply it effectively 
  • Share better practices and learnings from our experiences

Moderators
avatar for Lillian Cao, MBA

Lillian Cao, MBA

Director, New Product Planning, Taiho Oncology
Lillian Cao is a marketing, strategic planning, and commercial effectiveness leader recognized for strong collaboration, communication, and business analysis skills, with a track record of accelerating business growth in complex and challenging environments.  Her pharma/biotech commercial... Read More →

Speakers
avatar for Sophie Desbiens, Ph.D.

Sophie Desbiens, Ph.D.

Director of New Product Commercialization, Alnylam Pharmaceuticals
Sophie Desbiens, Ph.D., is Director of New Product Commercialization at Alnylam. Prior to joining Alnylam, Sophie worked at Genentech/Roche, where she held commercial and insights roles in Global Product Strategy. She also led the Data Program at NEWDIGS, an MIT-based consortium fostering... Read More →
avatar for Elaine Hughes

Elaine Hughes

Executive Director, Commercial Development, Bristol Myers Squibb
Elaine Hughes is Executive Director, Commercial Development for Immunology, Fibrosis & Neurology at BMS, leading New Product Planning and Business Development for those therapeutic areas. In this role, she and her team manage a portfolio of nearly 30 products from Discovery to Phase... Read More →
avatar for Alpesh Patel, MBA

Alpesh Patel, MBA

Vice President, Regulatory Affairs, Cellectis
Alpesh has over 20 years of experience in providing strategic regulatory guidance in Clinical Development, Post-Marketing, Labeling, Advertising and Promotional, and CMC in all phases of the drug development process in the U.S. and globally. He has worked in large pharma, mid-size... Read More →


Wednesday February 3, 2021 3:15pm - 4:00pm EST

4:00pm EST

"Meet the Speakers" Zoom Party
Missing out on the networking aspect of live events? Your question didn’t get answered during the Q&A portion of a session? Grab a snack and mingle with today’s speakers and attendees in this zoom breakout room.

Wednesday February 3, 2021 4:00pm - 4:30pm EST